PLRX
Pliant Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Pliant Therapeutics is a biotechnology company focused on developing therapies for the treatment of fibrotic diseases.
Pliant Therapeutics
PLRX
Pliant Therapeutics is a biotechnology company focused on developing therapies for the treatment of fibrotic diseases.
Price history of Pliant Therapeutics
Price history of Pliant Therapeutics
Performance & Momentum
Strategic Analysis
Pliant Therapeutics • 2026
Pliant Therapeutics is developing innovative treatments targeting fibrotic diseases, a segment of medical biotechnology with a high unmet medical need. It positions itself in a specialized therapeutic niche with research programs that have high scientific potential, but it faces clinical and financial challenges.
Strengths
- Focus on fibrotic diseases, an underexploited area with high therapeutic potential
- Recognized scientific expertise in targeted medical research
- Positioned in a rapidly growing biotechnology sector
Weaknesses
- Long-term history of very degraded financial and stock performance
- Current absence of news or catalysts that could create positive momentum
Momentum
Momentum is neutral with a confirmed declining trend over several years, reflecting operational difficulties and the lack of recent catalysts. This situation necessitates heightened vigilance and a speculative investment approach, awaiting major clinical advancements or valuation upgrades.
Similar stocks to Pliant Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
